Follow‐up of patch test reactivity to sesquiterpene lactone mix in a patient successfully treated with dupilumab for severe airborne allergic contact dermatitis
Contact Dermatitis · 2023
DOI: 10.1111/cod.14367 ↗At a glance
Leserbrief in Contact Dermatitis, 2023. Written by Rosella Gallo and 4 co-authors. Institution: Section of Dermatology, Department of Health Sciences (DISSAL), University of Genoa and IRCCS Ospedale Policlinico San Martino, Genoa, Italy. Major MEDLINE topics: Dermatitis, Allergic Contact, Sesquiterpenes. Cited 4 times so far (Crossref); 7 references.
Abstract (original language)
Aucun résumé disponible.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Section of Dermatology, Department of Health Sciences (DISSAL), University of Genoa and IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Cite
APA
Gallo, R., Trave, I., Castelli, R., Gasparini, G., & Parodi, A. (2023). Follow‐up of patch test reactivity to sesquiterpene lactone mix in a patient successfully treated with dupilumab for severe airborne allergic contact dermatitis. Contact Dermatitis. https://doi.org/10.1111/cod.14367
Vancouver
Gallo R, Trave I, Castelli R, Gasparini G, Parodi A. Follow‐up of patch test reactivity to sesquiterpene lactone mix in a patient successfully treated with dupilumab for severe airborne allergic contact dermatitis. Contact Dermatitis. 2023. doi:10.1111/cod.14367
BibTeX
@article{Gallo2023,
author = {Gallo, Rosella and Trave, Ilaria and Castelli, Riccardo and Gasparini, Giulia and Parodi, Aurora},
title = {Follow‐up of patch test reactivity to sesquiterpene lactone mix in a patient successfully treated with dupilumab for severe airborne allergic contact dermatitis},
journal = {Contact Dermatitis},
year = {2023},
doi = {10.1111/cod.14367}
}
EUVIMED